Expectations trend
FY2027 · fiscal year ending 2027-12-31 · fmp
C&F Financial Corp. (CFFI)
NASDAQFinancialsBanks - RegionalSnapshot 2026-11-04
$108.35-3.46%
Close 2026-11-05 · 1-day change
NASDAQFinancialsBanks - RegionalSnapshot 2026-11-04
The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.
Next-FY EPS estimate change · 30 days
9.99 → 10.28 EPS · FY ending Dec 31, 2027 · 1 analyst
One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.
Change in the same fiscal period’s mean EPS estimate from Oct 5, 2026 to Nov 4, 2026: (new ÷ prior − 1). Contributor count changed from 1 to 1; this is not the number of analysts revising. The ±10% axis is a display range.
The EPS and P/E reference is not available for CFFI yet.
| Measure / period | Management expectations | Analyst expectations |
|---|
Management figures unavailable.
Current consensus figures unavailable.
Three published thesis conditions, with dated milestones shown separately.
| Key Factor | Why It Matters | Current Status | Break Condition | Latest Evidence |
|---|---|---|---|---|
Dividend per share at $0.48 or higher | C&F Financial pays a steady and growing dividend of $0.48 per share. | Intact | Dividend per share falls below $0.46 next year | Dividend per share: $0.48 per share FY2026-Q2; GAAP. Published target: >= $0.48 per share. The stored target says 2026-Q1; this source reports FY2026-Q2. Fiscal/calendar alignment needs review. Aug 10, 20260.48 USD/share · source valueLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Compare these dated observations with the operating requirements above
FY2027 · fiscal year ending 2027-12-31 · fmp
The evidence, the remaining questions, and what comes next
No recovery evidence is reported in the available driver assessments.
Next earnings date unavailable
Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.
Observed price history; separate from operating scenarios
The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.
CFFI is a community banking business with a measured growth and portfolio-restructuring story, rather than a high-growth thesis. The long-term thesis is intact, though the latest earnings miss changed the signal from mildly favorable to mixed.
Valuation is close to peers, at a modest premium, and the expectations gap is slightly negative. The evidence labels the pricing as justified, with low fragility, so it does not point to a large mismatch between expectations and execution risk.
In the near term, the October earnings miss and a run of misses make earnings quality a concern, despite a low assessed miss risk. Over the multi-year view, community banking loans and deposits have grown, while securities restructuring has raised yields but also caused a pretax loss; management execution is mixed overall.
A guidance cut on the next call would be a meaningful negative, and the evidence also flags rate cuts as a sector headwind. Continued earnings strength and higher guidance from financial-sector peers could support the backdrop, while execution on loan and deposit growth remains important.
Over the next one to three years, CFFI’s thesis rests on continued operating growth and improved earnings execution, with the latest miss adding near-term uncertainty. Not investment advice.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
| A primary condition in C&F Financial Corp.'s published investment case. The stated target is EPS >= $2.08 per share. |
| Intact |
| EPS falls below $1.90 in 2026 |
Diluted EPS: $2.55 per share FY2026-Q3; GAAP. Published target: EPS >= $2.08 per share. Target period is not explicitly aligned with this observation. Oct 26, 20262.55 USD/share · source valueLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Revenue growth near 8.5% per year | A primary condition in C&F Financial Corp.'s published investment case. The stated target is >= 8% YoY. | Intact | Revenue growth falls below 6% YoY next year | Revenue growth: 6.47% FY2026-Q3; GAAP. Published target: >= 8% YoY. Target period is not explicitly aligned with this observation. Oct 26, 20266.465804 percent · calculatedLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Stored thesis · Jul 8, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.
$9.99 → $10.28 · observed estimates
$0.17B → $0.16B · observed estimates
One fiscal period and provider throughout. At least five contributors are required for each plotted metric; missing coverage stays a gap. Axes show the observed range. Counts measure coverage, not revisions.
| Snapshot | EPS | Revenue | EPS / revenue analysts |
|---|---|---|---|
| 2026-09-29 | $9.99 | $173,777,000 | 1 / 1 |
| 2026-09-30 | $9.99 | $173,777,000 | 1 / 1 |
| 2026-10-01 | $9.99 | $173,777,000 | 1 / 1 |
| 2026-10-02 | $9.99 | $173,800,000 | 1 / 1 |
| 2026-10-03 | $9.99 | $173,800,000 | 1 / 1 |
| 2026-10-04 | $9.99 | $173,800,000 | 1 / 1 |
| 2026-10-05 | $9.99 | $173,800,000 | 1 / 1 |
| 2026-10-06 | $9.99 | $173,800,000 | 1 / 1 |
| 2026-10-07 | $9.99 | $173,800,000 | 1 / 1 |
| 2026-10-08 | $9.99 | $173,800,000 | 1 / 1 |
| 2026-10-09 | $9.99 | $173,800,000 | 1 / 1 |
| 2026-10-10 | $9.99 | $173,800,000 | 1 / 1 |
| 2026-10-11 | $9.99 | $173,800,000 | 1 / 1 |
| 2026-10-12 | $9.99 | $173,800,000 | 1 / 1 |
| 2026-10-13 | $9.99 | $173,800,000 | 1 / 1 |
| 2026-10-14 | $9.99 | $173,800,000 | 1 / 1 |
| 2026-10-15 | $9.99 | $173,800,000 | 1 / 1 |
| 2026-10-16 | $9.99 | $173,800,000 | 1 / 1 |
| 2026-10-17 | $9.99 | $173,800,000 | 1 / 1 |
| 2026-10-18 | $9.99 | $173,800,000 | 1 / 1 |
| 2026-10-19 | $9.99 | $173,800,000 | 1 / 1 |
| 2026-10-20 | $9.99 | $173,800,000 | 1 / 1 |
| 2026-10-21 | $9.99 | $173,800,000 | 1 / 1 |
| 2026-10-22 | $9.99 | $173,800,000 | 1 / 1 |
| 2026-10-23 | $9.99 | $173,800,000 | 1 / 1 |
| 2026-10-24 | $9.99 | $173,800,000 | 1 / 1 |
| 2026-10-25 | $9.99 | $173,800,000 | 1 / 1 |
| 2026-10-26 | $9.99 | $173,800,000 | 1 / 1 |
| 2026-10-27 | $9.99 | $173,800,000 | 1 / 1 |
| 2026-10-28 | $10.28 | $163,300,000 | 1 / 1 |
| 2026-10-29 | $10.28 | $163,300,000 | 1 / 1 |
| 2026-10-30 | $10.28 | $163,300,000 | 1 / 1 |
| 2026-10-31 | $10.28 | $163,300,000 | 1 / 1 |
| 2026-11-01 | $10.28 | $163,300,000 | 1 / 1 |
| 2026-11-02 | $10.28 | $163,300,000 | 1 / 1 |
| 2026-11-03 | $10.28 | $163,300,000 | 1 / 1 |
| 2026-11-04 | $10.28 | $163,300,000 | 1 / 1 |
Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.
Latest: 1 Buy / Strong Buy · 0 Hold · 0 Sell / Strong Sell
Recent actions · Oct 6–Nov 4 · 2 recorded
Individual price-target observations are unavailable.
0 raises · 0 cuts · 0 unchanged · 0 without a comparable prior
Oct 6, 2026–Nov 4, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.
3 of 3 published conditions remain under pressure or need verification. The next results need to address those conditions.
The dated weekly assessment and its assumptions are available in Read detailed Outlook.